Replies to post #40094 on Relief Therapeutics Holding AG (RLFTF)

[193638]

WOW, now it sounds like snake oil. This is a penny stock if it could do all you say big pharma would just buy it outright. I have seen Dr. JJ interviews they are paid for advertisements. Just my opinion GLTA

[changes_iv]

Dear Ms Pegs1, if I understood correctly, you will be asking your pulmonologist for Zyesami IV off-label once approved to market 2021, yes? Once Zyesami IV is approved to market, what is to keep Zyesami inhaler from going to market as well …2021? Get that one off-label as well!!! >>>>

The most abundant neuropeptide in the lung is the vasoactive intestinal peptide (VIP), which is a potent muscle relaxant and has therefore been suggested in the therapy of chronic inflammatory lung diseases, including COPD [15,16]. In experimental conditions, VIP has a positive inotropic and chronotropic effect.

https://www.karger.com/Article/Fulltext/439228

ALSO KNOWN AS VIP, THE FINAL MAGIC WAND